Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and the Currentum in connection with the acquisition of Elektro-Emanuel
Mandate

Vinge advises Axcel VI and the Currentum in connection with the acquisition of Elektro-Emanuel

June 19, 2024 M&A Banking and Finance Real Estate and Construction Employment and Benefits

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elektro-Emanuel AB. The company carries out electrical installations for both companies and private individuals and has offices in four cities in western Sweden.

The acquisition is subject to customary regulatory approvals.

Vinge’s team consisted of responsible partner Christina Kokko together with Carl Fredrik Wachtmeister and Alexander Rüdén (M&A), Calle Tengwall Pagels and Frithiof Hallgren Wallin (Banking and finance), Niclas Lindblom (Construction), Hanna Kövamees (Real property), Narin Melazade and Jonatan Stentorp (Labor Law), Daniel Wendelsson, David Olander and Hilda Ivarsson (Regulatory) and Johanna Engström (Transaction Support Coordinator).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025